These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 151733)

  • 1. Mass spectrometric identification and selected ion monitoring quantitation of gamma-amino-butyric acid (GABA) in human lumbar cerebrospinal fluid.
    Faull KF; DoAmaral JR; Berger PA; Barchas JD
    J Neurochem; 1978 Oct; 31(4):1119-22. PubMed ID: 151733
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of GABA in human CSF by gas liquid chromatography and mass spectrometry.
    Huizinga JD; Teelken AW; Muskiet FA; vd Meulen J; Wolthers BG
    N Engl J Med; 1977 Mar; 296(12):692. PubMed ID: 138796
    [No Abstract]   [Full Text] [Related]  

  • 3. Schizophrenia, tardive dyskinesia, and brain GABA.
    Perry TL; Hansen S; Jones K
    Biol Psychiatry; 1989 Jan; 25(2):200-6. PubMed ID: 2564786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA levels in CSF of patients with psychiatric disorders.
    Gold BI; Bowers MB; Roth RH; Sweeney DW
    Am J Psychiatry; 1980 Mar; 137(3):362-4. PubMed ID: 7356067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between central monoaminergic systems: dopamine-serotonin.
    Roccatagliata G; Albano C; Cocito L; Maffini M
    J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1159-62. PubMed ID: 160445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly specific and sensitive determination of gamma-aminobutyric acid by gas chromatography mass spectrometry.
    Colby BN; McCaman MW
    Biomed Mass Spectrom; 1978 Mar; 5(3):215-9. PubMed ID: 630062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa.
    Gerner RH; Hare TA
    Am J Psychiatry; 1981 Aug; 138(8):1098-101. PubMed ID: 7258390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Pyrrolidinone in human cerebrospinal fluid: a major constituent of total gamma-aminobutyric acid.
    Haegele KD; Schwartz JJ; Schoun J; Schmitt AH; Schechter PJ
    J Neurochem; 1987 Nov; 49(5):1402-6. PubMed ID: 3668531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.
    Enna SJ; Stern LZ; Wastek GJ; Yamamura HI
    Arch Neurol; 1977 Nov; 34(11):683-5. PubMed ID: 143928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 13. GABA levels in cerebrospinal fluid of patients with Huntington's chorea: a preliminary report.
    Glaeser BS; Vogel WH; Oleweiler DB; Hare TA
    Biochem Med; 1975 Apr; 12(4):380-5. PubMed ID: 126061
    [No Abstract]   [Full Text] [Related]  

  • 14. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-Aminobutyric acid concentration in cerebrospinal fluid in schizophrenia.
    McCarthy BW; Gomes UR; Neethling AC; Shanley BC; Taljaard JJ; Potgieter L; Roux JT
    J Neurochem; 1981 Apr; 36(4):1406-8. PubMed ID: 7264636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid.
    Post RM; Ballenger JC; Hare TA; Bunney WE
    Neurology; 1980 Sep; 30(9):1008-11. PubMed ID: 7191529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
    Kuroda H
    Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
    Gerner RH; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Hare TA; Shaywitz BA; Cohen DJ
    Am J Psychiatry; 1984 Dec; 141(12):1533-40. PubMed ID: 6209989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific and sensitive determination of gamma aminobutyric acid in CSF and brain tissue by gas chromatography-mass spectrometry.
    Schaaf JM; Teelken AW; Muskiet FA; Nagel G; Wolthers BG
    J Neurosci Methods; 1985 May; 13(3-4):257-65. PubMed ID: 4010335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.